Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers
Ceftizoxime (C<sub>13</sub>H<sub>12</sub>N<sub>5</sub>NaO<sub>5</sub>S<sub>2</sub>)is a parenteral, third-generationcephalosporin antibiotic used to treat bacterial infections including ear, nose, and throat infections. In this work, pectin...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/10/8/1452 |
id |
doaj-e5fc631a0b81420e8d856fc2b7dcccb8 |
---|---|
record_format |
Article |
spelling |
doaj-e5fc631a0b81420e8d856fc2b7dcccb82020-11-25T03:25:53ZengMDPI AGNanomaterials2079-49912020-07-01101452145210.3390/nano10081452Fabrication and Characterization of Ceftizoxime-Loaded Pectin NanocarriersPawan Kumar0Vinod Kumar1Ravinder Kumar2Catalin Iulian Pruncu3Department of Materials Science and Nanotechnology, Deenbandhu Chhotu Ram University of Science and Technology, Murthal 131039, IndiaDepartment of Bio and Nano Technology, Guru Jambheshwar University of Science and Technology, Hisar 125001, IndiaDepartment of Mechanical Engineering, Lovely Professional University, Phagwara 144411, IndiaMechanical Engineering Department, University of Birmingham, Birmingham B15 2TT, UKCeftizoxime (C<sub>13</sub>H<sub>12</sub>N<sub>5</sub>NaO<sub>5</sub>S<sub>2</sub>)is a parenteral, third-generationcephalosporin antibiotic used to treat bacterial infections including ear, nose, and throat infections. In this work, pectin has been used as a nanocarrier for ceftizoxime due to its high biocompatibility and non-toxicity with tunable surface properties. Ceftizoxime-loaded pectin nanocarriers (CPN) were successfully synthesized by the solvent displacement method. Optimization of nanoformulation was done by response surface methodology using Design-Expert software. The optimized formulation examined various in-vitro characterizations such as particle size, morphology, and FTIR studies. TEM results revealed irregular shape nanoparticles within the range of 29–110 nm. The in-vitro drug release using the dialysis method was performed after 24h where nanoformulation showed sustained drug release. Drug-loaded nanoparticles revealed good antimicrobial activity against <i>Bacillus cereus, Bacilluspolymyxa, Enterobacteraerogenes</i>, and<i>Pseudomonasaeruginosa</i>.https://www.mdpi.com/2079-4991/10/8/1452Ceftizoximepectinsolvent displacementnanocarriersantibacterial activity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pawan Kumar Vinod Kumar Ravinder Kumar Catalin Iulian Pruncu |
spellingShingle |
Pawan Kumar Vinod Kumar Ravinder Kumar Catalin Iulian Pruncu Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers Nanomaterials Ceftizoxime pectin solvent displacement nanocarriers antibacterial activity |
author_facet |
Pawan Kumar Vinod Kumar Ravinder Kumar Catalin Iulian Pruncu |
author_sort |
Pawan Kumar |
title |
Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers |
title_short |
Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers |
title_full |
Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers |
title_fullStr |
Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers |
title_full_unstemmed |
Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers |
title_sort |
fabrication and characterization of ceftizoxime-loaded pectin nanocarriers |
publisher |
MDPI AG |
series |
Nanomaterials |
issn |
2079-4991 |
publishDate |
2020-07-01 |
description |
Ceftizoxime (C<sub>13</sub>H<sub>12</sub>N<sub>5</sub>NaO<sub>5</sub>S<sub>2</sub>)is a parenteral, third-generationcephalosporin antibiotic used to treat bacterial infections including ear, nose, and throat infections. In this work, pectin has been used as a nanocarrier for ceftizoxime due to its high biocompatibility and non-toxicity with tunable surface properties. Ceftizoxime-loaded pectin nanocarriers (CPN) were successfully synthesized by the solvent displacement method. Optimization of nanoformulation was done by response surface methodology using Design-Expert software. The optimized formulation examined various in-vitro characterizations such as particle size, morphology, and FTIR studies. TEM results revealed irregular shape nanoparticles within the range of 29–110 nm. The in-vitro drug release using the dialysis method was performed after 24h where nanoformulation showed sustained drug release. Drug-loaded nanoparticles revealed good antimicrobial activity against <i>Bacillus cereus, Bacilluspolymyxa, Enterobacteraerogenes</i>, and<i>Pseudomonasaeruginosa</i>. |
topic |
Ceftizoxime pectin solvent displacement nanocarriers antibacterial activity |
url |
https://www.mdpi.com/2079-4991/10/8/1452 |
work_keys_str_mv |
AT pawankumar fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers AT vinodkumar fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers AT ravinderkumar fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers AT cataliniulianpruncu fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers |
_version_ |
1724595033439469568 |